Genome Wide Association Study of EFNB3 Polymorphism and Gestational Hypertension

To identify EFNB3 gene variants as hypertension risk markers to manage hypertension treatment by controlling oestrogen levels

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027479

Enrollment

Unknown

Registered

2019-11-15

Start date

2020-01-01

Completion date

Unknown

Last updated

2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Hypertension

Interventions

Gestational hypertion:N/A

Control group:N/A

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) BP > 140 and / or 90 mmHg after 20 weeks of pregnancy; 2) Single pregnancy.

Exclusion criteria

Exclusion criteria: 1) History of pre-pregnancy hypertension or antihypertensive drugs; 2) Chronic kidney disease; 3) There are other special circumstances or taking any medicine that may raise your blood pressure.

Design outcomes

Primary

Measure	Time frame
EFNB3 gene polymorphism;	—

Countries

China

Contacts

Public ContactJianhua Zhu

The First Affiliated Hospital, College of Medicine, Zhejiang University

zjh_john2015@163.com+86 13958039959

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026